BTNL2
protein-codingbutyrophilin like 2, the group of V-set domain containing|C2-set domain containing|Butyrophilins
Gene summary
This gene encodes a major histocompatibility complex, class II associated, type I transmembrane protein which belongs to the butyrophilin-like B7 family of immunoregulators. It is thought to be involved in immune surveillance, serving as a negative T-cell regulator by decreasing T-cell proliferation and cytokine release. The encoded protein contains an N-terminal signal peptide, two pairs of immunoglobulin-like domains, separated by a heptad peptide sequence, and a C-terminal transmembrane domain. Naturally occurring mutations in this gene are associated with sarcoidosis, rheumatoid arthritis, ulcerative colitis, inflammatory bowel disease, myositis, type 1 diabetes, systemic lupus erythematosus, acute coronary syndrome, and prostate cancer. [provided by RefSeq, May 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~13.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0012888
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BTNL2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001304561.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 1 | 3 | |||
| missense | 39 | 3 | 3 | 45 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 43 | 3 | 5 | 51 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001291490.1 | 7 | MANE Select | |
| Ensembl | ENSP00000390613.3 | 7 | MANE Select | |
| Ensembl | ENSP00000388434.2 | 2 | Standard | |
| Ensembl | ENSP00000420063.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Butyrophilin (BTN) family interactions
- Immune System
- Adaptive Immune System
Biological Process
- regulation of immune response
- T cell receptor signaling pathway
Molecular Function
- signaling receptor binding
Cellular Component
- plasma membrane
- external side of plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000454136
- Coding exons
- 7
- Length
- 13166
- Individuals with no LoFs
- 100966
- Homozygous LoFs
- 1860
- Heterozygous LoFs
- 22922
- Defined
- 125748
- p
- 0.104
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.50 | 194 | 263 | 0.739 | 0.0000135 | 3104 |
| Missense (PolyPhen) | 59 | 85.132 | 0.69304 | 1087 | ||
| Synonymous | 0.885 | 98 | 110 | 0.893 | 0.00000648 | 950 |
| Loss of Function | 0.546 | 17 | 19.6 | 0.867 | 8.40e-7 | 231 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.16 | 0.15 | notable |
| Latino/Admixed American | 0.19 | 0.18 | notable |
| Ashkenazi Jewish | 0.033 | 0.033 | notable |
| East Asian | 0.19 | 0.19 | notable |
| Finnish | 0.17 | 0.16 | notable |
| European (Non-Finnish) | 0.071 | 0.066 | notable |
| South Asian | 0.085 | 0.081 | notable |
| Other | 0.10 | 0.097 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Negative regulator of T-cell proliferation. {ECO:0000250}.;
- Disease
- DISEASE: Sarcoidosis 2 (SS2) [MIM:612387]: An idiopathic, systemic, inflammatory disease characterized by the formation of immune granulomas in involved organs. Granulomas predominantly invade the lungs and the lymphatic system, but also skin, liver, spleen, eyes and other organs may be involved. {ECO:0000269|PubMed:15735647}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A nucleotide transition affecting a splice donor site results in the use of an alternative splice site and the production of isoform 3. Individuals expressing isoform 3 have a higher risk for sarcoidosis.;
Essentials
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0448
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |